Sunday, June 01, 2025 11:07:51 AM
RMB. I may bail on ARDX as UNCY's OLC PDUFA date nears . I'd really like to know what Motts plan is .
Here we are going into June and no progress that I'm aware of getting Medicare coverage renewed for Xphozah .
The info I have on the TDAPA process is that if ARDX was to apply for TDAPA , they would have full coverage for 2-3 yrs and then 50% coverage for 3 yrs after that. . Thats a huge chunk of $ they aren't getting right now
Once UNCY's OLC is approved , they will immediately apply for TDAPA and have OLC on the market by end of year .
I can't see Mott doing nothing and just allowing UNCY to be the only new pho binder covered for Medicare patients .
Kiwi
Here we are going into June and no progress that I'm aware of getting Medicare coverage renewed for Xphozah .
The info I have on the TDAPA process is that if ARDX was to apply for TDAPA , they would have full coverage for 2-3 yrs and then 50% coverage for 3 yrs after that. . Thats a huge chunk of $ they aren't getting right now
Once UNCY's OLC is approved , they will immediately apply for TDAPA and have OLC on the market by end of year .
I can't see Mott doing nothing and just allowing UNCY to be the only new pho binder covered for Medicare patients .
Kiwi
Recent ARDX News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/26/2026 08:16:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:18:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:17:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:14:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:10:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 12:04:58 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 11:39:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 11:18:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 10:56:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 10:28:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 08:32:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/19/2026 08:27:44 PM
- Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 • GlobeNewswire Inc. • 05/19/2026 12:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 03:23:54 PM
- Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings • GlobeNewswire Inc. • 05/07/2026 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:02:43 PM
- Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/30/2026 08:01:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:03:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2026 08:01:36 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:05:05 PM
- Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings • GlobeNewswire Inc. • 04/27/2026 12:01:00 PM
- Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026 • GlobeNewswire Inc. • 04/23/2026 12:01:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 08:04:27 PM
- Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
